Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Reported Outcomes for XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma

NCT03852810 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03852810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03852810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Reported Outcomes for XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
February 25, 2019
Completion date
December 9, 2020
Enrollment
28 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma